Carmen Loquai
Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy.
Wagner N, Lenders M, Kühl K, Reinhardt L, Fuchß M, Ring N, Stäger R, Zellweger C, Ebel C, Kimeswenger S, Oellinger A, Amaral T, Forschner A, Leiter U, Klumpp B, Hoetzenecker W, Terheyden P, Mangana J, Loquai C, Cozzio A, Garbe C, Meier F, Eigentler T, Flatz L. Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy. Eur J Cancer 2023; 196:113425.
21.11.2023Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy.
21.11.2023Eur J Cancer 2023; 196:113425
Wagner Nikolaus, Lenders Max M, Kühl Kathrin, Reinhardt Lydia, Fuchß Milena, Ring Natalie, Stäger Ramon, Zellweger Caroline, Ebel Chiara, Kimeswenger Susanne, Oellinger Angela, Amaral Teresa, Forschner Andrea, Leiter Ulrike, Klumpp Bernhard, Hoetzenecker Wolfram, Terheyden Patrick, Mangana Joanna, Loquai Carmen, Cozzio Antonio, Garbe Claus, Meier Friedegund, Eigentler Thomas Kurt, Flatz Lukas
S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021.
Dippel E, Assaf C, Becker J, von Bergwelt-Baildon M, Bernreiter S, Cozzio A, Eich H, Elsayad K, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke C, Loquai C, Meiß F, Mitteldorf C, Wehkamp U, Nashan D, Nicolay J, Oschlies I, Schlaak M, Stranzenbach R, Moritz R, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R. S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021. J Dtsch Dermatol Ges 2022; 20:537-554.
01.04.2022S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021.
01.04.2022J Dtsch Dermatol Ges 2022; 20:537-554
Dippel Edgar, Assaf Chalid, Becker Jürgen C, von Bergwelt-Baildon Michael, Bernreiter Sophie, Cozzio Antonio, Eich Hans, Elsayad Khaled, Follmann Markus, Grabbe Stephan, Hillen Uwe, Klapper Wolfram, Klemke Claus-Detlev, Loquai Carmen, Meiß Frank, Mitteldorf Christina, Wehkamp Ulrike, Nashan Dorothee, Nicolay Jan P, Oschlies Ilske, Schlaak Max, Stranzenbach René, Moritz Rose, Stoll Christoph, Vag Tibor, Weichenthal Michael, Wobser Marion, Stadler Rudolf
S2k-Leitlinie - Kutane Lymphome (ICD10 C82-C86): Update 2021.
Dippel E, Assaf C, Becker J, von Bergwelt-Baildon M, Bernreiter S, Cozzio A, Eich H, Elsayad K, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke C, Loquai C, Meiß F, Mitteldorf C, Wehkamp U, Nashan D, Nicolay J, Oschlies I, Schlaak M, Stranzenbach R, Moritz R, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R. S2k-Leitlinie - Kutane Lymphome (ICD10 C82-C86): Update 2021. J Dtsch Dermatol Ges 2022; 20:537-555.
01.04.2022S2k-Leitlinie - Kutane Lymphome (ICD10 C82-C86): Update 2021.
01.04.2022J Dtsch Dermatol Ges 2022; 20:537-555
Dippel Edgar, Assaf Chalid, Becker Jürgen C, von Bergwelt-Baildon Michael, Bernreiter Sophie, Cozzio Antonio, Eich Hans, Elsayad Khaled, Follmann Markus, Grabbe Stephan, Hillen Uwe, Klapper Wolfram, Klemke Claus-Detlev, Loquai Carmen, Meiß Frank, Mitteldorf Christina, Wehkamp Ulrike, Nashan Dorothee, Nicolay Jan P, Oschlies Ilske, Schlaak Max, Stranzenbach René, Moritz Rose, Stoll Christoph, Vag Tibor, Weichenthal Michael, Wobser Marion, Stadler Rudolf
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
Wagner N, Schraag A, Klumpp B, Hoetzenecker W, Berking C, Richtig E, Ziemer M, Mangana J, Terheyden P, Loquai C, Nguyen V, Gebhardt C, Meier F, Diem S, Cozzio A, Flatz L, Röcken M, Garbe C, Gassenmaier M, Weide B, Leiter U, Lenders M, Kühl K, Reinhardt L, André F, Dudda M, Ring N, Ebel C, Stäger R, Zellweger C, Lang R, Paar M, Gussek P, Richtig G, Stürmer S, Kimeswenger S, Oellinger A, Forschner A, Eigentler T. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study. J Immunother Cancer 2021; 9
01.01.2021Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
01.01.2021J Immunother Cancer 2021; 9
Wagner Nikolaus, Schraag Amadeus, Klumpp Bernhard, Hoetzenecker Wolfram, Berking Carola, Richtig Erika, Ziemer Mirjana, Mangana Johanna, Terheyden Patrick, Loquai Carmen, Nguyen Van Anh, Gebhardt Christoffer, Meier Friedegund, Diem Stefan, Cozzio Antonio, Flatz Lukas, Röcken Martin, Garbe Claus, Gassenmaier Maximilian, Weide Benjamin, Leiter Ulrike, Lenders Max M, Kühl Kathrin, Reinhardt Lydia, André Fiona, Dudda Milena, Ring Natalie, Ebel Chiara, Stäger Ramon, Zellweger Caroline, Lang Roland, Paar Michael, Gussek Philipp, Richtig Georg, Stürmer Suzan H, Kimeswenger Susanne, Oellinger Angela, Forschner Andrea, Eigentler Thomas K
S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86)
Dippel E, Meiß F, Mestel D, Nashan D, Nicolay J, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Loquai C, Lamos C, Klemke C, Assaf C, Becker J, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich H, Follmann M, Grabbe S, Hillen U, Klapper W, Stadler R. S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86). J Dtsch Dermatol Ges 2018; 16:112-123.
01.01.2018S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86)
01.01.2018J Dtsch Dermatol Ges 2018; 16:112-123
Dippel Edgar, Meiß Frank, Mestel Dominik, Nashan Dorothee, Nicolay Jan P, Oschlies Ilske, Schlaak Max, Stoll Christoph, Vag Tibor, Weichenthal Michael, Wobser Marion, Loquai Carmen, Lamos Cristina, Klemke Claus-Detlev, Assaf Chalid, Becker Jürgen C, von Bergwelt-Baildon Michael, Beyer Marc, Cozzio Antonio, Eich Hans Theodor, Follmann Markus, Grabbe Stephan, Hillen Uwe, Klapper Wolfram, Stadler Rudolf
S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86)
Dippel E, Meiß F, Mestel D, Nashan D, Nicolay J, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Loquai C, Lamos C, Klemke C, Assaf C, Becker J, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich H, Follmann M, Grabbe S, Hillen U, Klapper W, Stadler R. S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86). J Dtsch Dermatol Ges 2017
27.12.2017S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86)
27.12.2017J Dtsch Dermatol Ges 2017
Dippel Edgar, Meiß Frank, Mestel Dominik, Nashan Dorothee, Nicolay Jan P, Oschlies Ilske, Schlaak Max, Stoll Christoph, Vag Tibor, Weichenthal Michael, Wobser Marion, Loquai Carmen, Lamos Cristina, Klemke Claus-Detlev, Assaf Chalid, Becker Jürgen C, von Bergwelt-Baildon Michael, Beyer Marc, Cozzio Antonio, Eich Hans Theodor, Follmann Markus, Grabbe Stephan, Hillen Uwe, Klapper Wolfram, Stadler Rudolf
S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86)
Dippel E, Meiß F, Mestel D, Nashan D, Nicolay J, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Loquai C, Lamos C, Klemke C, Assaf C, Becker J, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich H, Follmann M, Grabbe S, Hillen U, Klapper W, Stadler R. S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86). J Dtsch Dermatol Ges 2017; 15:1266-1273.
01.12.2017S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86)
01.12.2017J Dtsch Dermatol Ges 2017; 15:1266-1273
Dippel Edgar, Meiß Frank, Mestel Dominik, Nashan Dorothee, Nicolay Jan P, Oschlies Ilske, Schlaak Max, Stoll Christoph, Vag Tibor, Weichenthal Michael, Wobser Marion, Loquai Carmen, Lamos Cristina, Klemke Claus-Detlev, Assaf Chalid, Becker Jürgen C, von Bergwelt-Baildon Michael, Beyer Marc, Cozzio Antonio, Eich Hans Theodor, Follmann Markus, Grabbe Stephan, Hillen Uwe, Klapper Wolfram, Stadler Rudolf
S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86)
Dippel E, Meiß F, Mestel D, Nashan D, Nicolay J, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Loquai C, Lamos C, Klemke C, Assaf C, Becker J, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich H, Follmann M, Grabbe S, Hillen U, Klapper W, Stadler R. S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86). J Dtsch Dermatol Ges 2017; 15:1266-1273.
28.11.2017S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86)
28.11.2017J Dtsch Dermatol Ges 2017; 15:1266-1273
Dippel Edgar, Meiß Frank, Mestel Dominik, Nashan Dorothee, Nicolay Jan P, Oschlies Ilske, Schlaak Max, Stoll Christoph, Vag Tibor, Weichenthal Michael, Wobser Marion, Loquai Carmen, Lamos Cristina, Klemke Claus-Detlev, Assaf Chalid, Becker Jürgen C, von Bergwelt-Baildon Michael, Beyer Marc, Cozzio Antonio, Eich Hans Theodor, Follmann Markus, Grabbe Stephan, Hillen Uwe, Klapper Wolfram, Stadler Rudolf
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
Voskens C, Mateus C, Mohr P, Paetzold S, Satzger I, Schadendorf D, Schlaeppi M, Schuler G, Schuler-Thurner B, Trefzer U, Ulrich J, Vaubel J, von Moos R, Weder P, Wilhelm T, Göppner D, Dummer R, Klein C, Keller U, Goldinger S, Loquai C, Robert C, Kaehler K, Berking C, Bergmann T, Bockmeyer C, Eigentler T, Fluck M, Garbe C, Gutzmer R, Grabbe S, Hauschild A, Hein R, Hundorfean G, Justich A, Heinzerling L. The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network. PloS one 2013; 8:e53745.
14.01.2013The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
14.01.2013PloS one 2013; 8:e53745
Voskens Caroline J, Mateus Christine, Mohr Peter, Paetzold Sylvie, Satzger Imke, Schadendorf Dirk, Schlaeppi Marc, Schuler Gerold, Schuler-Thurner Beatrice, Trefzer Uwe, Ulrich Jens, Vaubel Julia, von Moos Roger, Weder Patrik, Wilhelm Tabea, Göppner Daniela, Dummer Reinhard, Klein Christina, Keller Ullrich, Goldinger Simone M, Loquai Carmen, Robert Caroline, Kaehler Katharina C, Berking Carola, Bergmann Tanja, Bockmeyer Clemens L, Eigentler Thomas, Fluck Michael, Garbe Claus, Gutzmer Ralf, Grabbe Stephan, Hauschild Axel, Hein Rüdiger, Hundorfean Gheorghe, Justich Armin, Heinzerling Lucie M